Target Name: MIR3616
NCBI ID: G100500814
Review Report on MIR3616 Target / Biomarker Content of Review Report on MIR3616 Target / Biomarker
MIR3616
Other Name(s): hsa-miR-3616-3p | microRNA 3616 | MicroRNA 3616 | hsa-mir-3616 | hsa-miR-3616-5p | mir-3616

MIR3616: A Drug Target / Disease Biomarker

MIR3616 is a drug target (or biomarker) that is being studied for its potential therapeutic effects in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

MIR3616 is a small molecule inhibitor of the protein kinase inhibitor (PKI) MIR3016, which is a potent inhibitor of multiple cellular signaling pathways, including the PI3K/Akt pathway. This pathway is involved in many cellular processes, including cell growth, differentiation, and survival, and is a target for many diseases, including cancer.

In preclinical studies, MIR3616 has been shown to be a potent inhibitor of PKI-MIR3016, with IC50 values in the low to mid micromolar range. This makes it a promising candidate for use as a drug or biomarker in a variety of diseases.

One of the key advantages of MIR3616 is its ability to selectively inhibit the PKI-MIR3016 pathway in cancer cells, while having minimal impact on healthy cells. This is important because many cancer treatments can have unintended side effects, such as reduced cell proliferation and survival. By selectively targeting the PKI-MIR3016 pathway, MIR3616 may be able to reduce the risk of unintended side effects while still delivering effective therapeutic effects.

In addition to its potential therapeutic benefits, MIR3616 also has the potential to serve as a biomarker for the PKI-MIR3016 pathway. By measuring the levels of MIR3016 and its metabolite in cancer cells, researchers may be able to monitor the effectiveness of MIR3616 as a therapeutic and determine the optimal dosage and timing for its use.

While further research is needed to fully understand the potential therapeutic and biomarker effects of MIR3616, its promising preclinical results suggest that it may be a valuable tool in the fight against cancer and other diseases.

Protein Name: MicroRNA 3616

The "MIR3616 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3616 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F | MIR378G | MIR378H | MIR378I | MIR379 | MIR380 | MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912